SEDANA MEDICAL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.45 SEK | +4.42% |
|
+2.51% | -3.07% |
| 05-22 | Sedana Medical AB Approves Election of Jens Viebke and Donna Haire as Board Members | CI |
| 04-25 | Transcript : Sedana Medical AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Presentation Operator MessageOperator (Operator)Hello and welcome to the Sedana Medical Q4 Rep...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Companyâs main shareholders are board members, Linc AB and Magiola Consulting AB.
Calendar
23/07/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
21.5
SEK
Average target price
35.5
SEK
Spread / Average Target
+65.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.07% | 201M | |
| -58.85% | 83.95M |
- Stock Market
- Equities
- SEDANA Stock
- News Sedana Medical AB
- Transcript : Sedana Medical AB, Q4 2021 Earnings Call, Feb 17, 2022
